French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...

The EC has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya to treat adults with ulcerative colitis (UC) ...

The FDA has granted rare paediatric disease and orphan drug designations for IN013, Innorna's mRNA therapeutic for Wilson's ...

Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...

Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.

China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-line treatment for CLL and small lymphocytic ...

Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...

Swiss company Dr Mueller, a leading provider of filtration equipment for pharmaceutical manufacturers worldwide, will be among the exhibitors ...

The quality and compliance of the content foundation you build today helps your organization scale efficiently in the future.

The FDA has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal antibody, penpulimab ...

Dr Mueller, a Swiss supplier of filtration equipment for the global pharmaceutical industry, will be exhibiting at this year’s ...

Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.